About
Generics
Areas of Focus
Categories
Generic DrugNJ, NY, PA
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
91
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT05285787Lead Sponsor
A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
PHASE2Completed
18 participants
Started: Mar 1, 2019 · Completed: Apr 30, 2021
NCT03005210Collaborator
A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)
PHASE1Completed
37 participants
Started: Nov 30, 2016 · Completed: Dec 31, 2016
NCT02953535Collaborator
A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)
PHASE1Completed
36 participants
Started: May 31, 2016 · Completed: Jun 30, 2016
Locations (1)
Headquarters
Laurelton, NY, United States
Map
Loading map...